Episode
Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience
- Podcast
- Neuro-Oncology: The Podcast
- Published
- Jun 15, 2026
- Duration seconds
- 972
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/ivosidenib-in-predominantly-recurrent-idh1-mutant-glioma-a-single-institution-experience.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener on their recent manuscript, titled " Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single institution experience."